- Cheson, B.D. (1992) "New antimetabolites in the treatment of human malignancies", Semin. Oncol. 19, 695-706.
- Galmarini, C.M., Mackey, J.R. and Dumontet, C. (2001) "Nucleoside analogues: mechanisms of drug resistance and reversal strategies". Leukenmia 15, 875-890.
- Gandhi, V., Estey, E., Keating, M.J. and Plunkett, W. (1993) "Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy", J. Clin. Oncol. 11. 116-124.
- Gandhi, V. and Plunkett, W. (1988) "Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells", Cancer Res. 48, 329-334.
- Gandhi, V., Estey, E., Keating, M.J., Chucrallah, A. and Plunkett, W. (1996) "Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemai: pharmacokinetic, pharmacodynamic. and molecular interactions". Blood 87. 256-264.
- Gandhi, V., Estey, E., Keating, M.J. and Plunkett, W. (1993) "Biochemical modulation of arabinosylcytosine for therapy of leukemias", Leuk. Lymphoma 10(Suppl.), 109-114.
- Plunkett, W. and Gandhi, V. (2001) "Purine and pyrimidine nucleoside analogs", Cancer Chemother. Biol. Response Modif. 19, 21-45.
- Carson, D.A., Wasson, D.B., Taetle, R. and Yu, A. (1983) "Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes", Blood 62, 737-743.
- Plunkett, W. and Gandhi, V. (1996) "Pharmacology of purine nucleoside analogues", Hematol. Cell Ther. 38(Suppl. 2), S67-S74.
- Gandhi, V. and Plunkett, W. (2002) "Cellular and clinical pharamacology of fludarabine", Clin. Phamacokinet. 41, 93-103.
- Schwaenen, C., Karakas, T. and Bergmann, L. (2002) "Bendamustine in the treatment of low-grad Non-Hodgkin's Iymphomas", Onkologie 23, 318-324.
- Kath, R., Blumenstengel, K., Fricke, H.J. and Hoffken, K. (2001) "Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia", J. Cancer Res. Clin. Oncol. 127, 48-54.
- Kroemer, G. and Reed, J.C. (2000) "Mitochondrial control of cell death", Nat. Med, 6, 513-519.
- Reed, J.C., Jurgensmeier, J.M. and Matsuyama, S. (1998) "Bel-2 family proteins and mitochondria", Biochim. Biophys. Acta 1366, 127-137.
- Boehere, S., Chow. K.U., Beske, F., Kukoc-Zivojnov, N., Pucetti, E., Ruthardt, M., et al. (2002) "In lymphatic cells Par-4 sensitizes at apoptosis by down-regulating Bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation", Cancer Res. 62, 1768-1775.
- Reed, J.C. (1999) "Dysregulation of apoptosis in cancer", J. Clin. Oncol. 17, 2941-2953.
- Chow, K.U., Boehrer, S., Geduldig, K., Kraphol, A., Hoelzer, D., Mitrou, P.S., et al. (2001) "In vitro induction of apoptosis in neoplastic cells in low-grade non-Hodgkin's lymphomas (NHL) using combinations of established cytotoxic drugs with bendamustine", Haematololgica 86, 485-493.
- Reers, M., Smiley, S.T., Mottola-Hartshorn, C., Chen, A., Lin, M. and Chen, L.B. (1995) "Mitochondrial membrane potential monitored by JC-1 dye", Methods Enzymol. 260, 406-417.
- Salvioli, S., Ardizzoni, A., Franceschi, C. and Cossarizza, A. (1997) "JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis". FEBS Lett. 411, 77-82.
- Chou, T.C. (1994) "Assessment of synergistic and antagonistic effects of chemotherapeutic agents in vitro", Contrib. Gynecol. Obstet. 19, 91-107.
- Chou, T.C., Motzer, R.J., Tong, Y. and Bosl, G.J. (1994) "Computerized quantitation of synergims and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design", J. Natl Cancer Inst. 86, 1517-1524.
- Debatin, K.M. (1999) "Activation of apoptosis pathways by anticancer drugs", Adv. Exp. Med. Biol. 457, 237-244.
- Gandhi, V., Kemena, A., Keating, M.J. and Plunkett, W. (1992) "Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia", Cancer Res. 52, 897-903.
- Kano, Y., Akutsu, M., Tsunoda, S., Suzuki, K., Ichikawa, A., Furukawa, Y., et al. (2000) "In vitro cytotoxic effects of fludarabine (2-Fara-A) in combination with commonly used antileukemic agants by isobologram analysis", Leukemia 14, 379-388.
- Tosi, P., Visani, G., Ottaviani, E., Manfori, S., Zinzani, P.L. and Tura, S. (1994) "Fludarabine + Ara-C + G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells", Leukemia 8, 2076-2082.
- Kornablau, S.M., Gandhi, V., Andreeff, H.M., Beran,M., Kantarjian, H.M., Koller. C.A., et al. (1996) "Clinical and laboratory studies of 2-chlorodeoxyadenosine ± cytosine arabmoside for relapsed or refractory acute myelogenous leukemia in adults", Leukemia 10, 1563-1569.
- Friesen, C., Herr, I., Krammer, P.H. and Debatin, K.M. (1996) "Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells", Nat. Med. 2, 574-577.
- Chow, K.U., Nowak, D., Boehrer, S., Ruthardt, M., Knau, A., Hoelzer, D. et al. (2002) "In lymphatic cells synergistic effects of apoptosis induced by chemotherapeutic drug combinations are dependent on enhanced cytochrome c-release, enforced caspase activation and concomitant down-regulation of XIAP and cIAPl", Submitted for publication.
- Achanta, G., Pelicano, H., Feng, L., Plunkett, W. and Huang, P. (2001) "Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage", Cancer Res. 61, 8723-8729.
In AML Cell Lines Ara-C Combined with Purine Analogues is Able to Exert Synergistic as Well as Antagonistic Effects on Proliferation, Apoptosis and Disruption of Mitochondrial Membrane Potential
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.